FDA Inspection 1117909 — Capital Eagle Inc.
The FDA completed an inspection of Capital Eagle Inc. on December 27, 2019 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 27, 2019
- Fiscal Year
- 2020
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Washington, DC (United States)